Vimarsana
Biggest News Aggregation in the World

Page 25 - Plus Reports News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Plus Reports. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Plus Reports Today - Breaking & Trending Today

Vitiligo Treatment Market Size Worth US$ 2.42 Billion With CAGR of 6.14% from 2022 to 2030 | Exclusive Report by Growth Plus Reports - Vimarsana News

Vitiligo Treatment Market Size Worth US$ 2.42 Billion With CAGR of 6.14% from 2022 to 2030 | Exclusive Report by Growth Plus Reports

NEW YORK, Sept. 5, 2022 /PRNewswire/ -- According to the latest report published by Growth Plus Reports, the global vitiligo treatment market is expected to clock US$ 2.42 billion by 2030 and

With 17.40% CAGR, Surgical Robots Market Size to Worth US$ 26.69 billion by 2030 - Vimarsana News

With 17.40% CAGR, Surgical Robots Market Size to Worth US$ 26.69 billion by 2030

/PRNewswire/ -- The global surgical robots market is expected to clock US$ 26.69 billion by 2030 to grow at 17.40% during the forecast period. As Growing...

Heart Attack Diagnostics Market Size Worth US$ 24.69 - Vimarsana News

Heart Attack Diagnostics Market Size Worth US$ 24.69

Pune, Sept. 01, 2022 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global heart attack diagnostics market is...

Lung Cancer Surgery Market Size Worth US$ 7.62 billion to grow at a CAGR of 3.5% from 2022 to 2030 - Vimarsana News

Lung Cancer Surgery Market Size Worth US$ 7.62 billion to grow at a CAGR of 3.5% from 2022 to 2030

NEW YORK, Aug. 30, 2022 /PRNewswire/ -- According to the latest report published by Growth Plus Reports, the global Lung Cancer Surgery Market size is anticipated to hit US$ 7.62 billion by

Antithrombin Market Size (2022-2030) Worth US$ 776.1 Million - Vimarsana News

Antithrombin Market Size (2022-2030) Worth US$ 776.1 Million

NEW YORK, Aug. 19, 2022 /PRNewswire/ -- The growing use of antithrombin in conjunction with heparin, and the increased risk of diseases like sepsis, intravascular coagulation, and myocardial